
Photo of Rachel Freedman taken from www.dana-farber.org
Jul 9, 2024, 06:03
Translational Breast Cancer Research Consortium Trial 022 – Annals of Oncology
Annals of Oncology made the following post on X:
“New article in press: Neratinib and Ado-Trastuzumab-Emtansine for Pre-treated and Untreated HER2-positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium Trial 022.
Waterfall plots displaying the best RANO-BM CNS responses.”
”
Read the study.
Source: Annals of Oncology/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 30, 2025, 04:13
Mar 30, 2025, 03:45
Mar 30, 2025, 03:26
Mar 30, 2025, 03:18
Mar 29, 2025, 23:14
Mar 29, 2025, 23:04